|
Delayed
Bombay S.E.
05:02:31 2026-11-09 EST
|
5-day change | 1st Jan Change | ||
| 1,385.00 INR | +1.01% |
|
+3.34% | +8.97% |
Company Valuation: Dr. Reddy's Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 714,500 | 767,655 | 1,024,969 | 953,168 | 1,044,616 | 1,153,806 | - | - |
| Change | - | 7.44% | 33.52% | -7.01% | 9.59% | 10.45% | - | - |
| Enterprise Value (EV) 1 | 703,980 | 719,330 | 960,383 | 928,633 | 1,011,902 | 1,123,463 | 1,104,550 | 1,077,877 |
| Change | - | 2.18% | 33.51% | -3.31% | 8.97% | 11.02% | -1.68% | -2.41% |
| P/E | 30.4x | 17.1x | 18.4x | 16.9x | 24.4x | 31.5x | 23.7x | 20.1x |
| PBR | 3.76x | 3.33x | 3.63x | 2.86x | 2.78x | 2.83x | 2.57x | 2.33x |
| PEG | - | 0.2x | 0.8x | 13.12x | -1x | -2.2x | 0.7x | 1.1x |
| Capitalization / Revenue | 3.33x | 3.11x | 3.67x | 2.93x | 3.11x | 3.28x | 2.93x | 2.67x |
| EV / Revenue | 3.28x | 2.92x | 3.44x | 2.85x | 3.01x | 3.2x | 2.81x | 2.49x |
| EV / EBITDA | 13.7x | 11.1x | 12.1x | 10.8x | 15.1x | 17.9x | 13.7x | 11.7x |
| EV / EBIT | 20.5x | 13.8x | 14.8x | 13.4x | 21.8x | 27x | 19.1x | 15.8x |
| EV / FCF | 52.3x | 15.1x | 33.1x | 49.1x | 30.3x | 31.2x | 33.3x | 24.8x |
| FCF Yield | 1.91% | 6.61% | 3.02% | 2.04% | 3.3% | 3.2% | 3% | 4.03% |
| Dividend per Share 2 | 6 | 8 | 8 | 8 | 8 | 7.482 | 8.373 | 9.13 |
| Rate of return | 0.7% | 0.87% | 0.65% | 0.7% | 0.64% | 0.54% | 0.6% | 0.66% |
| EPS 2 | 28.34 | 54.18 | 66.92 | 67.78 | 51.42 | 43.98 | 58.39 | 68.78 |
| Distribution rate | 21.2% | 14.8% | 12% | 11.8% | 15.6% | 17% | 14.3% | 13.3% |
| Net sales 1 | 214,391 | 246,697 | 279,164 | 325,535 | 335,933 | 351,282 | 393,171 | 432,374 |
| EBITDA 1 | 51,400 | 64,559 | 79,481 | 86,236 | 67,048 | 62,797 | 80,785 | 92,091 |
| EBIT 1 | 34,277 | 52,057 | 64,781 | 69,178 | 46,443 | 41,656 | 57,771 | 68,088 |
| Net income 1 | 23,568 | 45,073 | 55,779 | 56,544 | 42,850 | 36,498 | 49,207 | 57,692 |
| Net Debt 1 | -10,520 | -48,325 | -64,586 | -24,535 | -32,714 | -30,343 | -49,256 | -75,929 |
| Reference price 2 | 861.08 | 924.30 | 1,231.03 | 1,144.05 | 1,254.65 | 1,385.00 | 1,385.00 | 1,385.00 |
| Nbr of stocks (in thousands) | 829,771 | 830,526 | 832,611 | 833,152 | 832,596 | 833,073 | - | - |
| Announcement Date | 5/19/22 | 5/10/23 | 5/7/24 | 5/9/25 | 5/12/26 | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 31.13x | 3.16x | 17.68x | 0.55% | 12.31B | ||
| 39.62x | 13.42x | 28.51x | 0.5% | 1,258B | ||
| 40.43x | 6.79x | 19.09x | 1.93% | 679B | ||
| 37.52x | 8.51x | 17.57x | 2.38% | 518B | ||
| 20.98x | 5.12x | 12.74x | 2.57% | 390B | ||
| 104.15x | 5.94x | 25.33x | 2.32% | 367B | ||
| 23.47x | 5.94x | 14.26x | 2.69% | 307B | ||
| 24.46x | 4.89x | 13.77x | 1.79% | 293B | ||
| 23.75x | 7.3x | 13.55x | 2.19% | 252B | ||
| -39.18x | 7.27x | 45.77x | 1.98% | 210B | ||
| Average | 30.63x | 6.83x | 20.83x | 1.89% | 429B | |
| Weighted average by Cap. | 36.31x | 8.57x | 21.90x | 1.72% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DRREDDY Stock
- Valuation Dr. Reddy's Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















